Bromocriptine restores tolerance in estrogen-treated mice

Journal of Clinical Investigation

Volumn 106, Issue 11, 2000, Pages 1373-1379

  Peeva, Elena ^a   Grimaldi, Christine ^a   Spatz, Linda ^b   Diamond, Betty ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CELL DNA; DNA ANTIBODY; ESTRADIOL; ESTROGEN; IMMUNOGLOBULIN G; PROLACTIN; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN DEPOSITION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE;

EID: 0033660070     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10420     Document Type: Article

References (55)

1. Sex hormones, immune responses, and autoimmune diseases
2. Sex steroid regulation of autoimmunity
3. Sex steroids and the rheumatic diseases
4. Sex steroids, glucocorticoids, stress and autoimmunity
5. Hormonal regulation of immune responses
6. Sex hormones and autoimmune rheumatic disorders
7. 17β-Estradiol, but not 5α-Dihydrotestosterone, augments antibodies to double-stranded DNA in nonautoimmune C57BL/6J mice
8. Evaluation of estrogen and progesterone receptor expression in uterine mucosal lymphocytes
9. Regulation of prolactin secretion by estrogens: Physiological and pathological significance
10. Prolactin receptors on human lymphocytes and their regulation by cyclosporine
11. Prolactin receptors on large granular lymphocytes: Dual regulation by cyclosporin A
12. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations
13. Expression of prolactin and its receptor in human lymphoid cells
14. The role of prolactin in the pathogenesis of autoimmune disease
15. Prolactin, pregnancy and autoimmune disease
16. Prolactin as an immunoreactive agent
17. Endocrine, paracrine and autocrine actions of prolactin on immune cells
18. The immune effects of neuropeptides
19. Molecular actions of prolactin in the immune system
20. Pituitary hormones and immune function
21. Prolactin, immunoregulation, and autoimmune diseases
22. Prolactin and systemic lupus erythematosus
23. Prolactin and gonadal hormones: A key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus
24. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus
25. Efficacy of bromocriptine in an open label therapeutic trial for SLE
26. Prolactin: A stimulator o f disease activity in SLE
27. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease
28. Hyperprolactinemia in SLE: Association with disease
29. Correlation study between prolactin and androgens in male patients with SLE
30. Prolactin levels in men with SLE and RA
31. Prolactin levels in patients with SLE: A case controlled study
32. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power
33. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus
34. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases
35. Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters
36. Hyperprolactinemia in systemic lupus erythematosus
37. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations
38. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis
39. Bromocriptine in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled study
40. Premature death with bladder outlet obstruction and hyperprolactinemia in NZB/NZW mice treated with ethynil estradiol and 17βestradiol
41. Prolactin influences autoimmune disease activity in the female NZB/W mouse
42. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of SLE
43. Induction of tolerance to an IgG autoantibody
44. Characterization of anti-DNA B cells that escape negative selection
45. Lack of allelic exclusion permits autoreactive B cells to escape deletion
46. Light chain usage in anti ds DNA B cell subsets: Role in cell fate determination
47. Bcl-2 leads to expression of anti-DNA B cells but no nephritis: A model for a clinical subset
48. Estrogen upregulates Bcl-2 and blocks tolerance induction of naive B cells
49. Peptide inhibition of glomerular deposition of an anti-DNA antibody
50. Production of monoclonal antibodies: Strategy and tactics
51. Estrogen and progesterone interactions in the control of gonadotropin and prolactin secretion
52. Prolactin receptor expression by splenocytes from rats in various hormonal states
53. Bromocriptine has little effect on murine lymphocytes, the immunomodulatory effect being mediated by suppression of prolactin secretion
54. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro
55. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro